- International Studies of Infarct Survival
The International Studies of Infarct Survival (ISIS) were four
randomized controlled trial s of severaldrug s for treating suspected acutemyocardial infarction ("heart attack"). More than 134,000 patients from over 20 countries took part in four large simple trials between 1981 and 1993, coordinated fromOxford , England.citation
last1 = Hennekens | first1 = Charles H.
year = 1998
title = Trials of Thrombolytic Therapy: the International Studies of Infarct Survival Experience
journal = Journal of Interventional Cardiology
volume = 11
pages = 1
doi = 10.1111/j.1540-8183.1998.tb00089.x] Citation
last = Hennekens | first = Charles H.
last2 = Skerrett | first2 = P.J.
year = 2005
title = International Studies of Infarct Survival (ISIS)
doi = 10.1002/0470011815.b2a01031
journal = Encyclopedia of Biostatistics]ISIS-1
The First International Study of Infarct Survival (ISIS-1) was a
placebo -controlled trial of thebeta-blocker atenolol . It recruited 16,027 patients and was completed in 1985. [citation
year = 1986
author = ISIS-1 (Second International Study of lnfarct Survival) Collaborative Group
title = Randomised trial of intravenous atenolol among 16027 cases of suspected acute myocardialinfarction: ISIS-1
journal = The Lancet
volume = 328
pages = 57-66
doi = 10.1016/S0140-6736(88)92833-4]ISIS-2
The Second International Study of Infarct Survival (ISIS-2) was a 2×2 factorial
placebo -controlled trial ofaspirin and thethrombolytic drugstreptokinase . It recruited 17,187 patients and was completed in 1988. [citation
year = 1988
author = ISIS-2 (Second International Study of lnfarct Survival) Collaborative Group
title = Randomised Trial of Intravenous Streptokinase, Oral Aspirin, Both, or Neither Among 17 187 Cases of Suspected Acute Myocardial Infarction: ISIS-2
journal = The Lancet
volume = 332
pages = 349-360
doi = 10.1016/S0140-6736(88)92833-4]ISIS-3
The Third International Study of Infarct Survival (ISIS-3) was a 3×2 factorial trial that compared the three
thrombolytic drugsstreptokinase ,tissue plasminogen activator (tPA) andanistreplase to each other, and also compared theanticoagulant heparin to no heparin. All patients were also givenaspirin . It recruited 41,299 patients and was completed in 1991.citation
author = ISIS-3 (Third International Study of lnfarct Survival) Collaborative Group
year = 1992
title = ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction
journal = The Lancet
volume = 339
pages = 753-770
doi = 10.1016/0140-6736(92)91893-D]ISIS-4
The Fourth International Study of Infarct Survival (ISIS-4) was a 2×2×2 factorial
placebo -controlled trial of theangiotensin-converting enzyme inhibitor (ACE inhibitor )captopril ,mononitrate andmagnesium sulphate . It recruited 58,050 patients and was completed in 1993.citation
author = ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group
year = 1995
title = ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction
journal = The Lancet
volume = 345
pages = 669-682
doi = 10.1016/S0140-6736(95)90865-X]ee also
*
GISSI
*Thrombolysis In Myocardial Infarction (TIMI)References
Wikimedia Foundation. 2010.